CECC confirms 41,670 more COVID-19 cases, including 41,430 domestic cases and 240 imported cases

CECC confirms 45,470 more COVID-19 cases, including 45,269 domestic cases and 201 imported cases

CECC confirms 49,708 more COVID-19 cases, including 49,540 domestic cases and 168 imported cases

CECC confirms 47,051 more COVID-19 cases, including 46,795 domestic cases and 256 imported cases

CECC confirms 234 more cases of Omicron subvariants, including 174 domestic cases and 60 imported cases

CECC confirms 25,583 more COVID-19 cases, including 25,346 domestic cases and 237 imported cases

CECC confirms 32,128 more COVID-19 cases, including 31,854 domestic cases and 274 imported cases

CECC confirms 35,830 more COVID-19 cases, including 35,594 domestic cases and 236 imported cases

CECC confirms 34,260 more COVID-19 cases, including 34,020 domestic cases and 240 imported cases

First batch of preventative monoclonal antibody therapy Evusheld purchased by CECC to be distributed to provide better protection for individuals with weak immune systems in Taiwan